{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:16:34Z","timestamp":1790648194918,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11060-017-2388-x","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T21:49:14Z","timestamp":1489441754000},"page":"401-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model"],"prefix":"10.1007","volume":"132","author":[{"given":"James C.","family":"League-Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Lester-McCully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaefali","family":"Shandilya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Ronner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"issue":"3","key":"2388_CR1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ (2013) Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36(3):437\u2013449","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2388_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/17425240903405581","volume":"7","author":"S Pasha","year":"2010","unstructured":"Pasha S, Gupta K (2010) Various drug delivery approaches to the central nervous system. Expert Opin Drug Deliv 7(1):113\u2013135","journal-title":"Expert Opin Drug Deliv"},{"key":"2388_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","volume":"5","author":"MI Vanan","year":"2015","unstructured":"Vanan MI, Eisenstat DD (2015) DiPG in children\u2013what can we learn from the past? Front Oncol 5:237","journal-title":"Front Oncol"},{"issue":"5","key":"2388_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/cns.13.37","volume":"2","author":"KE Warren","year":"2013","unstructured":"Warren KE (2013) Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncol 2(5):427\u2013435","journal-title":"CNS Oncol"},{"issue":"2","key":"2388_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2500\/ajra.2015.29.4149","volume":"29","author":"MM Miyake","year":"2015","unstructured":"Miyake MM, Bleier BS(2015) The blood\u2013brain barrier and nasal drug delivery to the central nervous system. Am J Rhinol Allergy 29(2):124\u2013127","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"2388_CR6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","volume":"12","author":"A Pires","year":"2009","unstructured":"Pires A et al (2009) Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12(3):288\u2013311","journal-title":"J Pharm Pharm Sci"},{"issue":"1\u20132","key":"2388_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","volume":"337","author":"HR Costantino","year":"2007","unstructured":"Costantino HR et al (2007) Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 337(1\u20132):1\u201324","journal-title":"Int J Pharm"},{"issue":"7","key":"2388_CR8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/era.10.77","volume":"10","author":"I Panagiotou","year":"2010","unstructured":"Panagiotou I, Mystakidou K (2010) Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications. Expert Rev Anticancer Ther 10(7):1009\u20131021","journal-title":"Expert Rev Anticancer Ther"},{"key":"2388_CR9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321044","volume":"40","author":"C Bitter","year":"2011","unstructured":"Bitter C, Suter-Zimmermann K, Surber C (2011) Nasal drug delivery in humans. Curr Probl Dermatol 40:20\u201335","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"2388_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","volume":"21","author":"D Mittal","year":"2014","unstructured":"Mittal D et al (2014) Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv 21(2):75\u201386","journal-title":"Drug Deliv"},{"issue":"1","key":"2388_CR11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"PG Djupesland","year":"2013","unstructured":"Djupesland PG (2013) Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res 3(1):42\u201362","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"2388_CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/00498250902893775","volume":"39","author":"NJ Attkins","year":"2009","unstructured":"Attkins NJ et al (2009) Predictability of intranasal pharmacokinetics in man using pre-clinical pharmacokinetic data with a dopamine 3 receptor agonist, PF-219061. Xenobiotica 39(7):523\u2013533","journal-title":"Xenobiotica"},{"issue":"4","key":"2388_CR13","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99(4):1654\u20131673","journal-title":"J Pharm Sci"},{"issue":"7","key":"2388_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64(7):614\u2013628","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2388_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11(1):1\u201318","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2388_CR16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","volume":"7","author":"NJ Johnson","year":"2010","unstructured":"Johnson NJ, Hanson LR, Frey WH (2010) Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm 7(3):884\u2013893","journal-title":"Mol Pharm"},{"issue":"3","key":"2388_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","volume":"8","author":"FW Merkus","year":"2007","unstructured":"Merkus FW, van den Berg MP (2007) Can nasal drug delivery bypass the blood\u2013brain barrier?: questioning the direct transport theory. Drugs R D 8(3):133\u2013144","journal-title":"Drugs R D"},{"issue":"3","key":"2388_CR18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","volume":"152","author":"RG Thorne","year":"2008","unstructured":"Thorne RG et al (2008) Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience 152(3):785\u2013797","journal-title":"Neuroscience"},{"issue":"3","key":"2388_CR19","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","volume":"5","author":"M Woensel van","year":"2013","unstructured":"van Woensel M et al (2013) Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM? Cancers (Basel) 5(3):1020\u20131048","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2388_CR20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/mp900275s","volume":"7","author":"T Shingaki","year":"2010","unstructured":"Shingaki T et al (2010) Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Mol Pharm 7(5):1561\u20131568","journal-title":"Mol Pharm"},{"issue":"6","key":"2388_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","volume":"5","author":"PG Djupesland","year":"2014","unstructured":"Djupesland PG, Messina JC, Mahmoud RA (2014) The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview. Ther Deliv 5(6):709\u2013733","journal-title":"Ther Deliv"},{"issue":"2","key":"2388_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1215\/15228517-2007-052","volume":"10","author":"R Hashizume","year":"2008","unstructured":"Hashizume R et al (2008) New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol 10(2):112\u2013120","journal-title":"Neuro Oncol"},{"issue":"3","key":"2388_CR23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11060-013-1346-5","volume":"116","author":"A Peterson","year":"2014","unstructured":"Peterson A et al (2014) A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option. J Neurooncol 116(3):437\u2013446","journal-title":"J Neurooncol"},{"issue":"12","key":"2388_CR24","first-page":"5625","volume":"33","author":"DAF CO","year":"2013","unstructured":"CO, D.A.F. et al (2013) Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation. Anticancer Res 33(12):5625\u20135631","journal-title":"Anticancer Res"},{"issue":"3","key":"2388_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1022592913323","volume":"61","author":"M Patel","year":"2003","unstructured":"Patel M et al (2003) Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. J Neurooncol 61(3):203\u2013207","journal-title":"J Neurooncol"},{"issue":"4","key":"2388_CR26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-007-0519-3","volume":"61","author":"SL Stapleton","year":"2008","unstructured":"Stapleton SL et al (2008) Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates. Cancer Chemother Pharmacol 61(4):647\u2013652","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"2388_CR27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00280-015-2711-1","volume":"75","author":"DE Cole","year":"2015","unstructured":"Cole DE et al (2015) Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model. Cancer Chemother Pharmacol 75(5):923\u2013928","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"2388_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1258\/la.2012.150312","volume":"46","author":"U Albus","year":"2012","unstructured":"Albus U (2012) Guide for the care and use of laboratory animals (8th edn). Lab Anim 46(3):267\u2013268","journal-title":"Lab Anim"},{"key":"2388_CR29","unstructured":"Mygind N, Upper airway: structure, function and therapy, in in aerosol in medicine. Princples, diagnoses, and therapy. 1985, Elsevier, Amsterdam, pp\u00a01\u201320"},{"issue":"1","key":"2388_CR30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/chromatography3010004","volume":"3","author":"CJ Peer","year":"2016","unstructured":"Peer CJ et al (2016) Quantification of temozolomide in nonhuman primate fluids by isocratic ultra-high performance liquid chromatography-tandem mass spectrometry to study brain tissue penetration following intranasal or intravenous delivery. Separations 3(1):4","journal-title":"Separations"},{"key":"2388_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2307\/3430686","volume":"85","author":"JR Harkema","year":"1990","unstructured":"Harkema JR (1990) Comparative pathology of the nasal mucosa in laboratory animals exposed to inhaled irritants. Environ Health Perspect 85:231","journal-title":"Environ Health Perspect"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2388-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2388-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:37:33Z","timestamp":1568914653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2388-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2388"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2388-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}